This topic contains a solution. Click here to go to the answer

Author Question: If we have a repeated-measures design with subjects receiving four levels of a treatment, we assume ... (Read 19 times)

Awilson837

  • Hero Member
  • *****
  • Posts: 509
If we have a repeated-measures design with subjects receiving four levels of a treatment, we assume that
 
  a. the correlations among the levels will be zero.
  b. the correlations among the levels will be 1.0
  c. the correlations among the levels will be random.
  d. the correlations among the levels will all be about the same.

Question 2

For repeated-measures designs with one independent variable (Time),
 
  a. subjects served under all levels of the independent variable.
  b. subjects served under only some of the levels of the independent variable.
  c. subjects served under only one level of the independent variable.
  d. none of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

dominiqueenicolee

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

D

Answer to Question 2

A





 

Did you know?

Hip fractures are the most serious consequences of osteoporosis. The incidence of hip fractures increases with each decade among patients in their 60s to patients in their 90s for both women and men of all populations. Men and women older than 80 years of age show the highest incidence of hip fractures.

Did you know?

The first successful kidney transplant was performed in 1954 and occurred in Boston. A kidney from an identical twin was transplanted into his dying brother's body and was not rejected because it did not appear foreign to his body.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library